# OnCo record genelux (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/genelux/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "genelux" ;
  schema:name "Genelux"@en ;
  schema:alternateName "Genelux Corporation"@en ;
  schema:description "Genelux is a United States-based biotechnology company running 2 late-stage cancer trials of olvimulogene nanivacirepvec and Olvimulogene nanivacirepvec in ovarian cancer and non-small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/genelux/>, <https://www.genelux.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Genelux_Corporation> ;
  owl:sameAs <http://www.wikidata.org/entity/Q25326575> ;
  schema:citation <https://www.genelux.com>, <https://clinicaltrials.gov/search?lead=Genelux%20Corporation> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/olvimulogene-nanivacirepvec/> ;
  onco:trials <https://onco.cc/trials/nct06463665/> .